Current Trial
A Phase II Study of GW786034 Using a Randomized Discontinuation Design in Patients with Locally Recurrent or Metastatic Clear-Cell Renal Cell Carcinoma

https://doi.org/10.3816/CGC.2006.n.011Get rights and content

First page preview

First page preview
Click to open first page preview

References (8)

  • M Murai et al.

    Renal cell carcinoma: etiology, incidence and epidemiology

    Curr Opin Urol

    (2004)
  • RJ Motzer et al.

    Phase 2 trials of SU011248 show antitumor activity in second-line therapy for patients with metastatic renal cell carcinoma (RCC)

    J Clin Oncol

    (2005)
  • DF McDermott et al.

    Application of IL-2 and other cytokines in renal cancer

    Expert Opin Biol Ther

    (2004)
  • J Folkman

    Tumor angiogenesis: therapeutic implications

    N Eng J Med

    (1983)
There are more references available in the full text version of this article.

Cited by (0)

Electronic forwarding or copying is a violation of US and International Copyright Laws.

Authorization to photocopy items for internal or personal use, or the internal or personal use of specific clients, is granted by CIG Media Group, LP, ISSN #1558-7673, provided the appropriate fee is paid directly to Copyright Clearance Center, 222 Rosewood Drive, Danvers, MA 01923 USA 978-750-8400.

View full text